HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S-Nitrosoglutathione protects the spinal bladder: novel therapeutic approach to post-spinal cord injury bladder remodeling.

AbstractAIMS:
Bladder and renal dysfunction are secondary events of the inflammatory processes induced by spinal cord injury (SCI). S-Nitrosoglutathione (GSNO), an endogenous nitrosylating agent is pleiotropic and has anti-inflammatory property. Hence, GSNO ameliorates inflammatory sequelae observed in bladder and renal tissues after SCI. Thus, we postulate that GSNO will improve the recovery of micturition dysfunction by quenching the bladder tissue inflammation associated with SCI.
METHODS:
Contusion-based mild SCI was induced in female Sprague-Dawley rats. Sham operated rats served as the controls. SCI rats were gavaged daily with GSNO (50 µg/kg) or vehicle. Bladder function was assessed by urodynamics at 2 and 14 days following SCI. Urine protein concentration and osmolality were measured. Bladder and kidney tissues were analyzed by histology and immunofluorescence for a variety of endpoints related to inflammation.
RESULTS:
Two days after SCI, urodynamics demonstrated a hyperreflexive bladder with overflow and no clear micturition events. By Day 14, vehicle animals regained a semblance of a voiding cycle but with no definite intercontraction intervals. GSNO-treated SCI-rats showed nearly normal cystometrograms. Vehicle-treated SCI rats had increased bladder wet weight, proteinuria, and urine osmolality at Day 14, which was reversed by GSNO treatment. In addition, the SCI-induced increase in immune cell infiltration, collagen deposition, iNOS, and ICAM-1 expression and apoptosis were attenuated by GSNO.
CONCLUSIONS:
These results indicate that oral administration of GSNO hastens the recovery of bladder function after mild contusion-induced SCI through dampening the inflammation sequelae. These findings also suggest that GSNO-mediated redox modulation may be a novel therapeutic target for the treatment of mild SCI-induced renal and bladder dysfunction.
AuthorsAnandakumar Shunmugavel, Mushfiquddin Khan, Francis M Hughes Jr, J Todd Purves, Avtar Singh, Inderjit Singh
JournalNeurourology and urodynamics (Neurourol Urodyn) Vol. 34 Issue 6 Pg. 519-26 (Aug 2015) ISSN: 1520-6777 [Electronic] United States
PMID24853799 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2014 Wiley Periodicals, Inc.
Chemical References
  • Intercellular Adhesion Molecule-1
  • S-Nitrosoglutathione
  • Nitric Oxide Synthase Type II
Topics
  • Animals
  • Contusions (complications)
  • Cystitis (drug therapy, etiology)
  • Female
  • Intercellular Adhesion Molecule-1 (biosynthesis)
  • Nitric Oxide Synthase Type II (biosynthesis)
  • Organ Size
  • Proteinuria (drug therapy, etiology)
  • Rats
  • Rats, Sprague-Dawley
  • S-Nitrosoglutathione (therapeutic use)
  • Spinal Cord Injuries (complications)
  • Urinary Bladder (pathology)
  • Urinary Bladder Diseases (pathology, prevention & control)
  • Urination Disorders (drug therapy, etiology)
  • Urodynamics

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: